State Street® SPDR® S&P® Pharmaceuticals ETF XPH

Medalist Rating as of | See State Street Investment Hub

Morningstar’s Analysis XPH

Will XPH outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

State Street® SPDR® S&P® PhrmctlsETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings XPH

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 24.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Crinetics Pharmaceuticals Inc

3.76 17M
Healthcare

MBX Biosciences Inc

2.98 14M
Healthcare

AtaiBeckley Inc

2.92 14M
Healthcare

Definium Therapeutics Inc Ordinary Shares

2.83 13M
Healthcare

Enliven Therapeutics Inc

2.15 10M
Healthcare

Alumis Inc

2.14 10M
Healthcare

Nuvation Bio Inc Ordinary Shares - Class A

2.10 10M
Healthcare

Amylyx Pharmaceuticals Inc

1.99 9M
Healthcare

Trevi Therapeutics Inc

1.92 9M
Healthcare

Harrow Inc

1.90 9M
Healthcare

Sponsor Center